ReviewJournal of pain research2026
Effect of Perineural Dexamethasone on the Duration of Analgesia in Paravertebral Block: A Meta-Analysis.
Review in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this meta-analysis was to evaluate the effect of perineural (PN) dexamethasone on the duration of analgesia in paravertebral block (PVB). Methods: We systematically searched PubMed, Embase, Web of Science, The Cochrane Library, and CNKI up to October 2025 for relevant randomized controlled trials (RCTs) comparing PN dexamethasone to a placebo in PVB. The primary outcome was the duration of analgesia. The mean difference (MD) and the risk ratio (RR) were calculated for continuous and dichotomous outcomes, respectively. Trial sequential analysis (TSA) was also carried out to calculate the required information size (RIS). Results: Ten trials with 731 participants were included. PN dexamethasone prolonged the duration of analgesia by approximately 350 minutes compared with placebo. In the trial sequential analysis, the cumulative Z-curve crossed both the conventional boundary and the trial sequential monitoring boundary for benefit, and reached RIS. In addition, PN dexamethasone decreased Visual analogue scale (VAS) scores at 2 hours, 6 hours, 12 hours and 24 hours after surgery with lower incidence of postoperative nausea and vomiting (PONV, risk ratio [RR] 0.41; 95% CI 0.25 to 0.69) and less cumulative opioid consumption (MD = -8.85; 95% CI: -13.39 to -4.32). Conclusion: This study suggested PN dexamethasone effectively prolongs the duration of analgesia in PVB and reduces the cumulative opioid consumption. TSA suggested that no more trials are required to confirm that PN dexamethasone effectively prolongs the duration of analgesia in PVB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.